MARC details
000 -LEADER |
fixed length control field |
04298cam a2200577 i 4500 |
001 - CONTROL NUMBER |
control field |
ocn930023615 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240729131951.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
fixed length control field |
m d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr ||||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
150918s2015 nyu ob 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2020686509 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
019 ## - |
-- |
948511278 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
9781634839181 |
Qualifying information |
ebook |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
1634839188 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
1634838785 |
Qualifying information |
hardcover |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
9781634838788 |
Qualifying information |
hardcover |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
1100292 |
-- |
(N$T) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)930023615 |
Canceled/invalid control number |
(OCoLC)948511278 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
014000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
022000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
112000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
045000 |
Source |
bisacsh |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
MAIN |
245 00 - TITLE STATEMENT |
Title |
Acute myeloid leukemia : |
Subtitle |
signssymptoms, classification, and treatment options |
Statement of responsibility, etc |
|
Medium |
[E-Book] |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
New York : |
Name of producer, publisher, distributor, manufacturer |
Nova Biomedical, |
Date of production, publication, distribution, manufacture, or copyright notice |
[2015] |
300 ## - PHYSICAL DESCRIPTION |
Physical description |
1 online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
490 1# - SERIES TITLE |
Series statement |
Cancer etiology, diagnosis and treatments |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
505 0# - CONTENTS |
Contents |
ACUTE MYELOID LEUKEMIA SIGNS/SYMPTOMS, CLASSIFICATION AND TREATMENT OPTIONS ; ACUTE MYELOID LEUKEMIA SIGNS/SYMPTOMS, CLASSIFICATION AND TREATMENT OPTIONS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 CLINICAL PRESENTATION OF ACUTE MYELOID LEUKEMIA ; ABSTRACT ; INTRODUCTION ; INCIDENCE AND PATIENT CHARACTERISTICS ; SYMPTOMS ; ORGAN INVOLVEMENT ; Skin ; Ocular ; Oral ; Central Nervous System ; Cardiovascular ; Pulmonary ; Gastrointestinal ; Lymphoreticular ; Musculoskeletal ; LABORATORY FINDINGS ; Complete Blood Counts ; Coagulation Studies |
505 8# - CONTENTS |
Contents |
Electrolytes Leukocyte Larceny ; CLINICAL SYNDROMES ASSOCIATED WITH AML; Leukostasis ; Disseminated Intravascular Coagulation ; Tumor Lysis Syndrome ; Infection ; Extramedullary Disease ; CONCLUSION ; REFERENCES ; Chapter 2 PROGNOSIS OF CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA ; ABSTRACT ; INTRODUCTION ; Subtypes of CBF AML ; Clinical Prognostic Factors ; Molecular Prognostic Factors ; Cytogenetic Factors ; Minimal Residual Disease ; Other Factors ; CONCLUSION AND FUTURE PERSPECTIVES ; ACKNOWLEDGMENTS; REFERENCES; Chapter 3 PHILADELPHIA CHROMOSOME-POSITIVE ACUTE MYELOID LEUKEMIA |
505 8# - CONTENTS |
Contents |
ABSTRACT INTRODUCTION; Differentiating from Blast Phase Chronic Myeloid Leukemia ; ClinicopathologicFeatures ; Management ; Role of Chemotherapy ; Role of Tyrosine Kinase Inhibitors ; Allogeneic Stem Cell Transplantation ; Presence of Additional Abnormalities ; CONCLUSION ; CONFLICT OF INTEREST ; ACKNOWLEDGMENT ; REFERENCES ; Chapter 4 THERAPY OF OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA; ABSTRACT ; INTRODUCTION ; PROGNOSTIC FACTORS; Patient-Related Prognostic Factors ; Age ; Performance Status ; Comorbidities ; Other Patient-Related Prognostic Factors; Disease-Related Prognostic Factors |
505 8# - CONTENTS |
Contents |
WBC Count Cytogenetics ; Molecular Genetics ; Mutations ; Overexpression ; Multidrug Resistance ; Secondary AML ; Other Disease Related Prognostic Factors ; Response-Related Prognostic Factors ; TREATMENT ; Intensive Induction Chemotherapy; The Role of Cytarabine ; The Role of Anthracycline ; The Role of Other Cytotoxic Agents ; The Role of Gemtuzumab Ozogamicin ; The Role of Multidrug Resistance Modulators ; The Role of Growth Factors ; Non-Intensive Induction Chemotherapy ; The Role of BSC ; The Role of Low Dose Cytarabine (LDAC) ; The Role of Clofarabine |
505 8# - CONTENTS |
Contents |
The Role of Hypomethylating Agents Azacitidine ; Decitabine ; Postremission Chemotherapy ; CONCLUSION; REFERENCES ; INDEX |
590 ## - LOCAL NOTE (RLIN) |
Local note |
Master record variable field(s) change: 050, 082 |
650 #0 - SUBJECT HEADINGS |
Subject term |
Acute myeloid leukemia |
General subdivision |
Diagnosis. |
650 #0 - SUBJECT HEADINGS |
Subject term |
Acute myeloid leukemia |
General subdivision |
Treatment. |
700 1# - ADDED PERSONAL NAME |
Added personal author |
Garza, Juan M., |
Relator term |
editor. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Cancer etiology, diagnosis, and treatments. |
856 ## - ONLINE RESOURCE |
Uniform Resource Identifier |
<a href="#gotoholdings">#gotoholdings</a> |
Link text |
Access resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Suppress in OPAC |
Do not Suppress in OPAC |
588 ## - SOURCE OF DESCRIPTION NOTE |
Source of description note |
Description based on print version record. |
938 ## - |
-- |
ProQuest Ebook Central |
-- |
EBLB |
-- |
EBL4188992 |
938 ## - |
-- |
YBP Library Services |
-- |
YANK |
-- |
12652335 |
938 ## - |
-- |
EBSCOhost |
-- |
EBSC |
-- |
1100292 |
994 ## - |
-- |
92 |
-- |
N$T |